Heartburn Drugs Will Not Work Well For People Who Are Morbidly Obese
A third of Americans can not control their eating and tens of millions rely on heartburn and acid reflux medicine as a result
Tuesday, May 4, 2021 - Obesity is arguably the number one self-inflicted health-damaging condition that Americans suffer from. Americans have gotten the reputation of being extremely overweight to the point that it has become a national embarrassment. The internet is filled with photos of overweight shoppers at Walmart as if they represented most people in America. They do, however, represent about one-third of the 360 million Americans, as according to Healththline.com, "More than one-third of adults in the United States are obese. In the United States, 36.5 percent of adults are obese." Fast-food chains from fried chicken to greasy hamburgers and other types of foods are unhealthy to eat and lead to becoming overweight. As people‘s lifestyles get more stressful and their living expenses go up they work longer hours and have less time to prepare healthy meals. Overworked people instead rely on Burger King, KFC, and other fast-food franchises for a quick lunch or dinner. With obesity, however, comes heartburn and acid indigestion as overeating overfills the stomach preventing the esophageal sphincter from closing. The esophageal sphincter prevents cancer-causing stomach acid from rising to the esophagus and burning the delicate lining of the tube that connects the throat and the stomach. If acid indigestion repeatedly occurs a person can develop esophageal or throat cancer as the lining of the organs becomes irritated, burned, and possibly infected. Visit Zantac antacid cancer lawsuit to learn more.
Overweight people mistakenly have tried to combat their heartburn pain by taking drugs like Zantac and Prilosec that reduce the amount of acid that the stomach produces. WebMD identifies the two heartburn medicines as "histamine antagonists (H2 antagonists or H2 blockers) and proton pump inhibitors (PPIs).
Examples of H2 blockers available over the counter include Cimetidine (Tagamet HB), Famotidine (Pepcid AC), and Nizatidine. Ranitidine (Zantac) was recalled on April 1, 2020, by the Food and Drug Administration when it was found to contain NDMA, a highly carcinogenic compound in levels thought to be unhealthy. Reducing stomach acid production is unnatural and can damage the digestive system and also reinforce the habit of overeating. For obese people, heartburn may be nature‘s way of telling them to stop eating.
Overweight people that had been taking Zantac may have allegedly developed cancer of the stomach, bladder, esophagus, and other types of cancer. NDMA has been found in Zantac millions of times greater than the 96NGS per tablet that the FDA established as an allowable limit. Zantac cancer lawyers are helping people to file lawsuits against Sanofi and GlaxoSmithKline for failing to warn consumers about the heartburn drug naturally degrading to become carcinogenic. The Department of Justice has opened an investigation and accused the companies of lying to federal regulators. According to legal experts, lawsuits against the companies over Zantac cancer could grow to become the largest mass tort civil proceeding in US history.
